We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Technology Offers Identification, Genotyping, and Characterization of Emerging Organisms

By LabMedica International staff writers
Posted on 22 Apr 2010
A program with public health applications includes epidemiologic surveillance, monitoring of pandemic diseases, and identification of emerging or previously unknown agents.

The Plex-ID system employs a combination of molecular technologies, including polymerase chain reaction (PCR) for gene amplification and mass spectrometry analysis to characterize rapidly known and unknown organisms. More...
It is designed to address a significant unmet need by providing test results in six to seven hours instead of three or more days as required with current laboratory methods.

Plex-ID, a product of Abbott (Abbott Park, IL, USA), can identify a broad range of bacteria, viruses, fungi, and certain parasites, and provide information about drug resistance, virulence, and strain type. It has the potential to be a powerful and versatile tool for public health laboratories, according to David N. Sundwall, Ph.D., executive director, Utah Department of Health (UDH; Salt Lake City, UT, USA).

"Plex-ID addresses the complex challenges of microbial identification by detecting and characterizing both known and previously unknown organisms found in a variety of specimens," Dr. Sundwall said. "The high-throughput technology offers our laboratory rapid detection and correct identification of a broad range of pathogens."

Dr. Sundwall added that for disease surveillance, the Plex-ID technology would enable public health officials to track emergent strains as they evolve, mutate, and possibly become more dangerous.

Abbott announced that the Utah Department of Health is one of five sites in the United States to participate in Abbott's new Plex-ID Biopreparedness Evaluation Program (BPEP), which involves Abbott, the Association of Public Health Laboratories (APHL; Silver Spring, MD, USA) and five state public health labs. The announcement was made at a ribbon-cutting ceremony for UDH's new multipurpose, state-of the-art Unified State Lab (USL; Taylorsville, UT, USA), a 7525 m2 facility that houses a variety of public-health laboratories.

In addition to Utah, the evaluation program will be conducted at state public health laboratories in Oklahoma, Minnesota, New York, and Virginia. In 2009, Plex-ID was recognized by both the Scientist and the Wall Street Journal as a top scientific innovation of the year.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture, and marketing of medical products, diagnostics, and pharmaceutics.

Related Links:
Abbott
Utah Department of Health
Association of Public Health Laboratories
Unified State Lab


Gold Member
Automatic Hematology Analyzer
DH-800 Series
Portable Electronic Pipette
Mini 96
8-Channel Pipette
SAPPHIRE 20–300 µL
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researchers have developed two rapid blood tests for early Alzheimer’s detection (Photo courtesy of UConn)

Fast Low-Cost Alzheimer’s Tests Could Detect Disease in Early and Silent Stages

Early diagnosis remains one of the greatest challenges in combating Alzheimer’s disease, the most common cause of age-related dementia. With symptoms like memory loss and confusion typically appearing... Read more

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.